Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo

Zhi‐Feng Miao(Kaohsiung Medical University), Xiaoyun Mao(First Hospital of China Medical University), Xingyu Liu(Valley Medical Center), Jian Gao(Chengdu University of Traditional Chinese Medicine), Yingying Xu(Wannan Medical College), Tingting Zhao(Sun Yat-sen University), Huimian Xu(First Hospital of China Medical University), Feng Miao(Fourth Affiliated Hospital of China Medical University), Yi You(Army Medical University), Hao Xu(China Medical University)
Tumor Biology
December 17, 2013
10.1007/s13277-013-1472-x
Cited by 27

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Biomarkers of aging
|Science China Life Sciences|2023|362
Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis
|ACS Nano|2023|345